Scott M. Stoeger, Ph.D. - Publications
Affiliations: | 2007 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Pharmacology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2018 | Razidlo GL, Johnson HJ, Stoeger SM, Cowan KH, Bessho T, Lewis RE. Correction: KSR1 is required for cell cycle reinitiation following DNA damage. The Journal of Biological Chemistry. 293: 19136. PMID 30530853 DOI: 10.1074/Jbc.Aac118.006696 | 0.555 | |||
2009 | Razidlo GL, Johnson HJ, Stoeger SM, Cowan KH, Bessho T, Lewis RE. KSR1 is required for cell cycle reinitiation following DNA damage. The Journal of Biological Chemistry. 284: 6705-15. PMID 19147494 DOI: 10.1074/Jbc.M806457200 | 0.652 | |||
2009 | Stoeger SM, Cowan KH. Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines. Cancer Chemotherapy and Pharmacology. 63: 807-18. PMID 18661133 DOI: 10.1007/S00280-008-0794-7 | 0.59 | |||
2005 | Kim M, Yan Y, Kortum RL, Stoeger SM, Sgagias MK, Lee K, Lewis RE, Cowan KH. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity. Cancer Research. 65: 3986-92. PMID 15899786 DOI: 10.1158/0008-5472.Can-03-2334 | 0.609 | |||
2005 | Yan Y, Spieker RS, Kim M, Stoeger SM, Cowan KH. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation. Oncogene. 24: 3285-96. PMID 15735702 DOI: 10.1038/Sj.Onc.1208492 | 0.607 | |||
2004 | Sgagias MK, Wagner KU, Hamik B, Stoeger S, Spieker R, Huber LJ, Chodosh LA, Cowan KH. Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS. Cell Cycle (Georgetown, Tex.). 3: 1451-6. PMID 15492509 DOI: 10.4161/Cc.3.11.1211 | 0.574 | |||
Show low-probability matches. |